BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10943940)

  • 1. Comment on 'viability of the EUD and TCP concepts as reliable dose indicators'.
    Vaarkamp J; Zhu Y
    Phys Med Biol; 2000 Jul; 45(7):L11-6. PubMed ID: 10943940
    [No Abstract]   [Full Text] [Related]  

  • 2. Viability of the EUD and TCP concepts as reliable dose indicators.
    Ebert MA
    Phys Med Biol; 2000 Feb; 45(2):441-57. PubMed ID: 10701514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From physical dose constraints to equivalent uniform dose constraints in inverse radiotherapy planning.
    Thieke C; Bortfeld T; Niemierko A; Nill S
    Med Phys; 2003 Sep; 30(9):2332-9. PubMed ID: 14528955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RADBIOMOD: A simple program for utilising biological modelling in radiotherapy plan evaluation.
    Chang JH; Gehrke C; Prabhakar R; Gill S; Wada M; Lim Joon D; Khoo V
    Phys Med; 2016 Jan; 32(1):248-54. PubMed ID: 26549777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of dose distributions through the max and mean dose concept.
    Thieke C; Bortfeld T; Küfer KH
    Acta Oncol; 2002; 41(2):158-61. PubMed ID: 12102160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive radiotherapy in head and neck cancer is required to avoid tumor underdose.
    Castelli J; Simon A; Rigaud B; Chajon E; Thariat J; Benezery K; Vauleon E; Jegoux F; Henry O; Lafond C; de Crevoisier R
    Acta Oncol; 2018 Sep; 57(9):1267-1270. PubMed ID: 29706107
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of techniques for simulating set-up error and uncertainty in head and neck IMRT.
    Ploquin N; Kay I; Rangel-Baltazar A; Lau H; Dunscombe P
    Med Phys; 2006 Sep; 33(9):3213-9. PubMed ID: 17022214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor control probability (TCP) and normal tissue complication probability (NTCP) in head and neck cancer.
    Grégoire V
    Rays; 2005; 30(2):105-8. PubMed ID: 16294902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The theoretical benefit of beam fringe compensation and field size reduction for iso-normal tissue complication probability dose escalation in radiotherapy of lung cancer.
    Engelsman M; Remeijer P; van Herk M; Mijnheer B; Damen E
    Med Phys; 2003 Jun; 30(6):1086-95. PubMed ID: 12852532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EUD-based biological optimization for carbon ion therapy.
    Brüningk SC; Kamp F; Wilkens JJ
    Med Phys; 2015 Nov; 42(11):6248-57. PubMed ID: 26520717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head and Neck Margin Reduction With Adaptive Radiation Therapy: Robustness of Treatment Plans Against Anatomy Changes.
    van Kranen S; Hamming-Vrieze O; Wolf A; Damen E; van Herk M; Sonke JJ
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):653-60. PubMed ID: 27681762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques.
    Longobardi B; De Martin E; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Calandrino R
    Radiother Oncol; 2005 Nov; 77(2):148-56. PubMed ID: 16260056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitations of a convolution method for modeling geometric uncertainties in radiation therapy: the radiobiological dose-per-fraction effect.
    Song W; Battista J; Van Dyk J
    Med Phys; 2004 Nov; 31(11):3034-45. PubMed ID: 15587657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The modified linear-quadratic model of Guerrero and Li can be derived from a mechanistic basis and exhibits linear-quadratic-linear behaviour.
    Carlone M; Wilkins D; Raaphorst P
    Phys Med Biol; 2005 May; 50(10):L9-13; author reply L13-5. PubMed ID: 15876677
    [No Abstract]   [Full Text] [Related]  

  • 15. Estimation of a radiation time prolongation factor for intensity-modulated radiotherapy.
    Bakai A; Alber M; Nüsslin F
    Phys Med Biol; 2003 Jan; 48(2):N25-9. PubMed ID: 12587911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should single or distributed parameters be used to explain the steepness of tumour control probability curves?
    Daşu A; Toma-Daşu I; Fowler JF
    Phys Med Biol; 2003 Feb; 48(3):387-97. PubMed ID: 12608614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dosimetric and radiobiological impact of calculation grid size on head and neck IMRT.
    Srivastava SP; Cheng CW; Das IJ
    Pract Radiat Oncol; 2017; 7(3):209-217. PubMed ID: 27847266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment simulation approaches for the estimation of the distributions of treatment quality parameters generated by geometrical uncertainties.
    Baum C; Alber M; Birkner M; Nüsslin F
    Phys Med Biol; 2004 Dec; 49(24):5475-88. PubMed ID: 15724537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of surface and build-up region dose for intensity-modulated radiation therapy in head and neck cancer.
    Chung H; Jin H; Dempsey JF; Liu C; Palta J; Suh TS; Kim S
    Med Phys; 2005 Aug; 32(8):2682-9. PubMed ID: 16193799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy requirements for head and neck intensity-modulated radiation therapy based on observed dose response of the major salivary glands.
    Kapanen M; Collan J; Saarilahti K; Heikkonen J; Kairemo K; Tenhunen M
    Radiother Oncol; 2009 Oct; 93(1):109-14. PubMed ID: 19435641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.